Two senior officials at the FDA's drug promotion regulatory office have resigned, leading to speculation that a clampdown on some direct-to-consumer (DTC) advertising of medicines could be on the way.

Wall Street is in a downward pattern after days of volatility. Markets have been buffeted by developments in the conflict in ...

Wall Street is in a downward pattern after days of volatility. Markets have been buffeted by developments in the conflict in ...

Wall Street is in a downward pattern after days of volatility. Markets have been buffeted by developments in the conflict in ...